Top Line

The European Medicines Agency, the European Union’s drug regulator, has signed off on the emergency use of Merck’s COVID antiviral pill for adults who have tested positive as it prepares to make a decision on full approval by the end of the year. Said on Friday.

important facts

- Advertisement -

The Human Medicines Committee of the EMA said Statement Merck’s pill “could be used to treat adults with COVID-19 who do not need supplemental oxygen and who are at risk of developing severe COVID-19.”

The pill, which Merck developed with Ridgeback Therapeutics, should be administered within five days of the onset of symptoms or immediately after diagnosis of COVID, and should be taken twice a day for five days, EMA said,

- Advertisement -